Poster HF - Patient Care Pathways

801 - Utility of Intermacs Risk Classification at the Time of Assessment for Advanced Therapies

Presentation Number
801
Presenter
Session Name
PO-2-HF - Poster Session 2: Heart Failure
Date
Thu, Apr 12, 2018
Time
06:15 PM - 07:15 PM
Co-Authors

Previous Eposter
1072 - Pre-Transplant Neutrophil to Lymphocyte Ratio Predicts 30-day Readmission for Patients Undergoing Cardiac Transplantation

Next Eposters
988 - Ten-year Experience With CentriMag Ventricular Assist Device Use in Acute Myocardial Infarction and Cardiogenic Shock
1048 - Quality of Outpatient INR Control in Children Supported on a Ventricular Assist Device
1253 - Pre-Cannulation SOFA Score is a Strong Predictor of Vasoplegia in Veno-Arterial Extra-Corporal Life Support Patients
781 - Tacrolimus Trough Monitoring by Mass Spectroscopy is Associated With Acute Kidney Injury in Lung Transplant Recipients
630 - Outcomes After Lung Transplantation for Patients with Occupational Lung Diseases
1161 - Air Trapping on Lung Scintigraphy After Lung Transplantation: Predictors and Association with Survival
1043 - Characteristics and Outcomes of Pediatric Patients Supported with Ventricular Assist Device - A Multi-institutional Analysis
1044 - Iron Deficiency is Associated with Adverse Outcomes in Pediatric Heart Failure
1045 - BMI and Association with Outcomes in Pediatric Patients on Durable Ventricular Assist Device Support
1382 - Pump Fiction: A Tale of Acute Promyelocytic Leukemia Mimicking Pump Thrombosis